Lisdexamfetamine Dimesylate Capsule
Product Images NDC 72162-2216

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lisdexamfetamine Dimesylate (NDC 72162-2216). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This text appears to be a table or list containing information about a special population's characteristics and certain measurements. The table includes categories such as gender, age, renal impairment, end-stage renal disease, PK (possibly referring to pharmacokinetics), Cmax (presumably a measure of maximum concentration), AUC (possibly an abbreviation for area under the curve), fold change, and 90% confidence interval. The specific values within each category are not clear from the provided text.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
The text provided does not contain a useful description.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
FDA Label Image

Figure-6 (Figure 6)

Figure-6 (Figure 6)
FDA Label Image

Figure-7 (Figure 7)

Figure-7 (Figure 7)
FDA Label Image

Figure-8 (Figure 8)

Figure-8 (Figure 8)
FDA Label Image

Label (Lbl721622216)

Label (Lbl721622216)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.